Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Share-based Compensation: 2010-2024

Historic Share-based Compensation for CorMedix (CRMD) over the last 14 years, with Dec 2024 value amounting to $6.1 million.

  • CorMedix's Share-based Compensation rose 231.21% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.4 million, marking a year-over-year increase of 128.58%. This contributed to the annual value of $6.1 million for FY2024, which is 11.57% up from last year.
  • As of FY2024, CorMedix's Share-based Compensation stood at $6.1 million, which was up 11.57% from $5.5 million recorded in FY2023.
  • Over the past 5 years, CorMedix's Share-based Compensation peaked at $6.1 million during FY2024, and registered a low of $2.5 million during FY2020.
  • In the last 3 years, CorMedix's Share-based Compensation had a median value of $5.5 million in 2023 and averaged $5.2 million.
  • As far as peak fluctuations go, CorMedix's Share-based Compensation skyrocketed by 101.72% in 2021, and later declined by 19.30% in 2022.
  • Yearly analysis of 5 years shows CorMedix's Share-based Compensation stood at $2.5 million in 2020, then soared by 101.72% to $5.0 million in 2021, then dropped by 19.30% to $4.1 million in 2022, then soared by 35.00% to $5.5 million in 2023, then grew by 11.57% to $6.1 million in 2024.